Technical Study: Hospira, Alkermes, Theravance, and Celsion

         Technical Study: Hospira, Alkermes, Theravance, and Celsion

PR Newswire

LONDON, July 22, 2013

LONDON, July 22, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Friday, July 19, 2013, shares in healthcare companies ended mostly higher
even as the broader market ended on a mixed note after a few weak earnings
reports from the tech sector. The major movers in the healthcare sector
included Hospira Inc. (NYSE: HSP), Alkermes Plc (NASDAQ: ALKS), Theravance
Inc. (NASDAQ: THRX), and Celsion Corporation (NASDAQ: CLSN).
AAAResearchReports.com free coverage on HSP, ALKS, THRX, and CLSN is available
upon registration at:

http://www.aaaresearchreports.com/register/

Shares in Hospira Inc. edged higher on Friday even as the broader market ended
on a mixed note. The company's shares oscillated between $39.31 and $39.82
before finishing the day 0.91% higher at $39.78. A total of 947,084 shares
were traded which is below the daily average volume of 1.03 million. Hospira's
shares have gained 14.34% in the last one month, thus outperforming the S&P
500 which gained 6.26% in the same period. Moreover, the stock is currently
trading near its 52-week high of $39.95. Download free technical research on
HSP by signing up at:

http://www.AAAResearchReports.com/HSP072213.pdf

Alkermes Plc's stock rose sharply on Friday, extending its gains from previous
trading sessions. The company's shares ended the day 2.87% higher at $31.18
after oscillating between $29.89 and $31.39. A total of 865,611 shares were
traded which is below the daily average volume of 1.69 million. The company's
shares have gained 5.23% in the last three trading sessions, and 14.59% in the
past one month, thus outperforming the S&P 500. Furthermore, the stock is
currently trading above its 50-day and 200-day moving averages. Register now
and get access to free analysis on ALKS at:

http://www.AAAResearchReports.com/ALKS072213.pdf

Shares in Theravance Inc. moved lower on Friday, extending their losses for
the week. The company's shares ended the day 0.49% lower at $38.75 after
oscillating between $38.72 and $39.33. A total of 768,580 shares were traded
which is below the daily average volume of 1.30 million. The company's shares
fell by 7.94% last week as compared to a gain of 0.71% in the S&P 500. Despite
last week's losses, Theravance's shares have gained 3.07% in the last one
month. Sign up and read our complimentary report on THRX at:

http://www.AAAResearchReports.com/THRX072213.pdf

Shares in Celsion Corporation surged on Friday, extending their gains for the
week. The company's shares oscillated between $1.35 and $1.55 before finishing
the day 16.49% higher at $1.42. A total of 14.26 million shares were traded
which is above the daily average volume of 3.55 million. Celsion's shares
gained 25.66% last week, thus outperforming the S&P 500. In the last three
months, the stock has gained 78.62%, as compared to a gain of 8.80% in the
same period. The free report on CLSN can be downloaded by signing up now at:

http://www.AAAResearchReports.com/CLSN072213.pdf

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

SOURCE AAA Research Reports

Contact: Media Contact: AAAresearchreports.com, Phone #: +1-(646)-396-9126
 
Press spacebar to pause and continue. Press esc to stop.